FITPU Healthcare is a joint spin-off company (Singapore Reg. No. 201526619N) from Singapore’s Agency for Science, Technology and Research (A*STAR) and National Cancer Center Singapore with leading expertise in oncology imaging.
FITPU provides foremost solutions in assessing tissue functional properties from functional magnetic resonance imaging or functional computed tomography data to assist clinical decision making in the diagnosis and prognosis of medical conditions such as cancer or stroke. The product MItalytics includes tracer kinetic models such as distributed parameter model, approximated tissue homogeneity model, conventional compartment model, Tofts model and extended Tofts model for processing dynamic contrast-enhanced imaging data. MItalytics also provides diffusion-weighted imaging models such as intravoxel incoherent motion model, diffusion kurtosis imaging model, stretched-exponential model and mono-exponential model for processing multiple b values diffusion-weighted imaging data. The product has been approved by National Medical Products Administration, China.
FITPU is supported by SPRING Singapore’s Technology Enterprise Commercialisation Scheme (TECS).